======= NCL ======= == Gene Information == * **Official Symbol**: NCL * **Official Name**: nucleolin * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4691|4691]] * **UniProt**: [[https://www.uniprot.org/uniprot/P19338|P19338]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NCL&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NCL|Open PubMed]] * **OMIM**: [[https://omim.org/entry/164035|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Nucleolin is the major nucleolar protein of growing eukaryotic cells. It is found associated with intranucleolar chromatin and pre-ribosomal particles. It induces chromatin decondensation by binding to histone H1. It is thought to play a role in pre-rRNA transcription and ribosome assembly. May play a role in the process of transcriptional elongation. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats. {ECO:0000269|PubMed:10393184}. |RRM 1| |DNA topoisomerase binding| |positive regulation of transcription of nucleolar large rRNA by RNA polymerase I| |regulation of transcription of nucleolar large rRNA by RNA polymerase I| |positive regulation of transcription by RNA polymerase I| |mRNA 5-UTR binding| |telomeric DNA binding| |regulation of transcription by RNA polymerase I| |cellular response to epidermal growth factor stimulus| |response to epidermal growth factor| |cytoplasmic ribonucleoprotein granule| |response to leukemia inhibitory factor| |cellular response to leukemia inhibitory factor| |negative regulation of translation| |cell cortex| |negative regulation of cellular amide metabolic process| |ribonucleoprotein complex| |protein C-terminus binding| |angiogenesis| |regulation of translation| |regulation of cellular amide metabolic process| |blood vessel morphogenesis| |blood vessel development| |cellular response to growth factor stimulus| |vasculature development| |cardiovascular system development| |posttranscriptional regulation of gene expression| |response to growth factor| |tube morphogenesis| |tube development| |nucleolus| |circulatory system development| |anatomical structure formation involved in morphogenesis| |cellular response to cytokine stimulus| |negative regulation of cellular protein metabolic process| |identical protein binding| |response to cytokine| |negative regulation of protein metabolic process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-2.03| |[[:results:exp85|UM0129480 7μM R02 exp85]]|-1.85| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-1.8| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-1.75| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|1.72| |[[:results:exp483|FTY720 3μM R08 exp483]]|1.8| |[[:results:exp152|SGC2043 10μM R03 exp152]]|1.81| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|1.83| ^Gene^Correlation^ |[[:human genes:t:tceb3c|TCEB3C]]|0.47| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.461| |[[:human genes:p:psmb4|PSMB4]]|0.449| |[[:human genes:n:narfl|NARFL]]|0.443| |[[:human genes:r:rps2|RPS2]]|0.437| |[[:human genes:p:ppm1d|PPM1D]]|0.434| |[[:human genes:p:paf1|PAF1]]|0.432| |[[:human genes:o:orc6|ORC6]]|0.431| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.43| |[[:human genes:n:nol7|NOL7]]|0.426| |[[:human genes:h:hgc6.3|HGC6.3]]|0.421| |[[:human genes:u:utp3|UTP3]]|0.417| |[[:human genes:p:psma6|PSMA6]]|0.417| |[[:human genes:r:rpl6|RPL6]]|0.411| |[[:human genes:i:isy1|ISY1]]|0.41| |[[:human genes:r:rps19|RPS19]]|0.41| |[[:human genes:r:rrp7a|RRP7A]]|0.408| |[[:human genes:d:dimt1|DIMT1]]|0.405| |[[:human genes:s:sf3a3|SF3A3]]|0.403| |[[:human genes:b:bms1|BMS1]]|0.403| |[[:human genes:c:cactin|CACTIN]]|0.401| |[[:human genes:c:ctage4|CTAGE4]]|0.4| Global Fraction of Cell Lines Where Essential: 99/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|4/28| |blood|0/28| |bone|0/26| |breast|4/33| |central nervous system|14/56| |cervix|1/4| |colorectal|2/17| |esophagus|0/13| |fibroblast|1/1| |gastric|2/16| |kidney|10/21| |liver|1/20| |lung|5/75| |lymphocyte|3/16| |ovary|5/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|10/24| |soft tissue|3/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|3/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1855 * **Expression level (log2 read counts)**: 10.69 {{:chemogenomics:nalm6 dist.png?nolink |}}